IBIO iBio Inc

-0.0039 (-1.31%)
After Hours
Last Updated: 16:41:16
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 126,457
Bid Price
Ask Price
News (3)
Day High 0.305


52 Week Range


Day Low 0.292301
Company Name Stock Ticker Symbol Market Type
iBio Inc IBIO AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0039 -1.31% 0.2938 16:41:16
Open Price Low Price High Price Close Price Prev Close
0.305 0.292301 0.305 0.294 0.2977
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
458 126,457 $ 0.2973831 $ 37,606 - 0.14 - 3.66
Last Trade Time Type Quantity Stock Price Currency
16:41:16 formt 156 $ 0.2938 USD

iBio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.94M 16.80M - 2.38M -50.39M -3.00 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

iBio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No IBIO Message Board. Create One! See More Posts on IBIO Message Board See More Message Board Posts

Historical IBIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.32770.34280.29160.3165907518,497-0.0339-10.34%
1 Month0.31040.42840.2620.3202815656,302-0.0166-5.35%
3 Months0.62310.79940.2620.452993640,463-0.3293-52.85%
6 Months2.142.490.2620.7823351606,188-1.85-86.27%
1 Year0.3153.660.141.131,367,750-0.0212-6.73%
3 Years2.073.660.141.364,478,019-1.78-85.81%
5 Years0.887.850.051.866,656,064-0.5862-66.61%

iBio Description

iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: biologics development and licensing activities, conducted within iBio, Inc.